183 related articles for article (PubMed ID: 35419617)
1. Towards better prediction of xenobiotic genotoxicity: CometChip technology coupled with a 3D model of HepaRG human liver cells.
Barranger A; Le Hégarat L
Arch Toxicol; 2022 Jul; 96(7):2087-2095. PubMed ID: 35419617
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of an in vitro three-dimensional HepaRG spheroid model for genotoxicity testing using the high-throughput CometChip platform.
Seo JE; He X; Muskhelishvili L; Malhi P; Mei N; Manjanatha M; Bryant M; Zhou T; Robison T; Guo X
ALTEX; 2022; 39(4):583-604. PubMed ID: 35791290
[TBL] [Abstract][Full Text] [Related]
3. Three-dimensional HepaRG spheroids as a liver model to study human genotoxicity in vitro with the single cell gel electrophoresis assay.
Mandon M; Huet S; Dubreil E; Fessard V; Le Hégarat L
Sci Rep; 2019 Jul; 9(1):10548. PubMed ID: 31332230
[TBL] [Abstract][Full Text] [Related]
4. Quantitative comparison of in vitro genotoxicity between metabolically competent HepaRG cells and HepG2 cells using the high-throughput high-content CometChip assay.
Seo JE; Tryndyak V; Wu Q; Dreval K; Pogribny I; Bryant M; Zhou T; Robison TW; Mei N; Guo X
Arch Toxicol; 2019 May; 93(5):1433-1448. PubMed ID: 30788552
[TBL] [Abstract][Full Text] [Related]
5. High-throughput micronucleus assay using three-dimensional HepaRG spheroids for in vitro genotoxicity testing.
Seo JE; Li X; Le Y; Mei N; Zhou T; Guo X
Arch Toxicol; 2023 Apr; 97(4):1163-1175. PubMed ID: 36847820
[TBL] [Abstract][Full Text] [Related]
6. Performance of high-throughput CometChip assay using primary human hepatocytes: a comparison of DNA damage responses with in vitro human hepatoma cell lines.
Seo JE; Wu Q; Bryant M; Ren L; Shi Q; Robison TW; Mei N; Manjanatha MG; Guo X
Arch Toxicol; 2020 Jun; 94(6):2207-2224. PubMed ID: 32318794
[TBL] [Abstract][Full Text] [Related]
7. DMSO-free highly differentiated HepaRG spheroids for chronic toxicity, liver functions and genotoxicity studies.
Rose S; Cuvellier M; Ezan F; Carteret J; Bruyère A; Legagneux V; Nesslany F; Baffet G; Langouët S
Arch Toxicol; 2022 Jan; 96(1):243-258. PubMed ID: 34762139
[TBL] [Abstract][Full Text] [Related]
8. Genotoxicity assessment of eight nitrosamines using 2D and 3D HepaRG cell models.
Seo JE; Yu JZ; Xu H; Li X; Atrakchi AH; McGovern TJ; Bruno KLD; Mei N; Heflich RH; Guo X
Arch Toxicol; 2023 Oct; 97(10):2785-2798. PubMed ID: 37486449
[TBL] [Abstract][Full Text] [Related]
9. New methodological developments for testing the in vitro genotoxicity of nanomaterials: Comparison of 2D and 3D HepaRG liver cell models and classical and high throughput comet assay formats.
Varet J; Barranger A; Crochet C; Huet S; Hogeveen K; Le Hégarat L; Fessard V
Chemosphere; 2024 Feb; 350():140975. PubMed ID: 38142884
[TBL] [Abstract][Full Text] [Related]
10. From the Cover: Three-Dimensional (3D) HepaRG Spheroid Model With Physiologically Relevant Xenobiotic Metabolism Competence and Hepatocyte Functionality for Liver Toxicity Screening.
Ramaiahgari SC; Waidyanatha S; Dixon D; DeVito MJ; Paules RS; Ferguson SS
Toxicol Sci; 2017 Sep; 159(1):124-136. PubMed ID: 28633424
[TBL] [Abstract][Full Text] [Related]
11. Evaluating the mutagenicity of N-nitrosodimethylamine in 2D and 3D HepaRG cell cultures using error-corrected next generation sequencing.
Seo JE; Le Y; Revollo J; Miranda-Colon J; Xu H; McKinzie P; Mei N; Chen T; Heflich RH; Zhou T; Robison T; Bonzo JA; Guo X
Arch Toxicol; 2024 Jun; 98(6):1919-1935. PubMed ID: 38584193
[TBL] [Abstract][Full Text] [Related]
12. 3D organotypic HepaRG cultures as in vitro model for acute and repeated dose toxicity studies.
Mueller D; Krämer L; Hoffmann E; Klein S; Noor F
Toxicol In Vitro; 2014 Feb; 28(1):104-12. PubMed ID: 23850736
[TBL] [Abstract][Full Text] [Related]
13. A Preliminary Investigation of Embedding In Vitro HepaRG Spheroids into Recombinant Human Collagen Type I for the Promotion of Liver Differentiation.
Liao FC; Wang YK; Cheng MY; Tu TY
Polymers (Basel); 2022 May; 14(9):. PubMed ID: 35567092
[TBL] [Abstract][Full Text] [Related]
14. HepaRG microencapsulated spheroids in DMSO-free culture: novel culturing approaches for enhanced xenobiotic and biosynthetic metabolism.
Rebelo SP; Costa R; Estrada M; Shevchenko V; Brito C; Alves PM
Arch Toxicol; 2015 Aug; 89(8):1347-58. PubMed ID: 25107451
[TBL] [Abstract][Full Text] [Related]
15. Application of HepaRG cells for genotoxicity assessment: a review.
Guo X; Xu H; Seo JE
J Environ Sci Health C Toxicol Carcinog; 2024 Apr; ():1-24. PubMed ID: 38566478
[TBL] [Abstract][Full Text] [Related]
16. Advanced In Vitro HepaRG Culture Systems for Xenobiotic Metabolism and Toxicity Characterization.
Ashraf MN; Asghar MW; Rong Y; Doschak MR; Kiang TKL
Eur J Drug Metab Pharmacokinet; 2019 Aug; 44(4):437-458. PubMed ID: 30535757
[TBL] [Abstract][Full Text] [Related]
17. Performance of HepaRG and HepG2 cells in the high-throughput micronucleus assay for in vitro genotoxicity assessment.
Guo X; Seo JE; Petibone D; Tryndyak V; Lee UJ; Zhou T; Robison TW; Mei N
J Toxicol Environ Health A; 2020 Nov; 83(21-22):702-717. PubMed ID: 32981483
[TBL] [Abstract][Full Text] [Related]
18. Adaptation of the in vitro micronucleus assay for genotoxicity testing using 3D liver models supporting longer-term exposure durations.
Conway GE; Shah UK; Llewellyn S; Cervena T; Evans SJ; Al Ali AS; Jenkins GJ; Clift MJD; Doak SH
Mutagenesis; 2020 Sep; 35(4):319-330. PubMed ID: 32780103
[TBL] [Abstract][Full Text] [Related]
19. Functional polymer-dependent 3D culture accelerates the differentiation of HepaRG cells into mature hepatocytes.
Higuchi Y; Kawai K; Kanaki T; Yamazaki H; Chesné C; Guguen-Guillouzo C; Suemizu H
Hepatol Res; 2016 Sep; 46(10):1045-57. PubMed ID: 26724677
[TBL] [Abstract][Full Text] [Related]
20. Development of a human liver microphysiological coculture system for higher throughput chemical safety assessment.
Ip BC; Madnick SJ; Zheng S; van Tongeren TCA; Hall SJ; Li H; Martin S; Spriggs S; Carmichael P; Chen W; Ames D; Breitweiser LA; Pence HE; Bowling AJ; Johnson KJ; Cubberley R; Morgan JR; Boekelheide K
Toxicol Sci; 2024 May; 199(2):227-245. PubMed ID: 38335931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
